Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5662 of 5804
-
Brain training for HIV patients: a new hope for sharper thinking?
Knowledge-focused TerminatedPeople with HIV (PWH) often suffer from cognitive impairments known as HIV-Associated Neurocognitive Disorder (HAND). Cognitive impairments in PWH are not fully captured by traditional neurocognitive assessment; thus, we must examine cognitive performance both within a task (inco…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Midwives' views on teeth: a new survey could shape future dental advice
Knowledge-focused Not yet recruitingThis study aims to explore how midwives in Germany perceive their professional role in the context of oral health of pregnant women and young children. A nationwide, anonymous, non-interventional online survey will be conducted to assess self-perceived role, confidence in counse…
Sponsor: University Medical Center Goettingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
MS app study pulled before it even started
Knowledge-focused TerminatedMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Diagnosis is established by clinical assessment of persons with MS (PwMS), in combination with imaging and body fluid assessments. Treatment decisions in MS are mainly based on periodic…
Sponsor: Research Center for Clinical Neuroimmunology and Neuroscience Basel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Promising drug for rare nerve disease trial pulled before start
Disease control TerminatedThis study is designed to assess the long-term efficacy and clinical benefit of AT-007 in patients with CMT-SORD. This randomized, double-blind study will assess the effect of govorestat compared to placebo in patients with CMT-SORD for up to 36 months.
Phase: PHASE3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Scientists probe Fat's secret signals after a meal
Knowledge-focused Not yet recruitingThe purpose of this study is to understand the specific outflow and difference between normal weight and volunteers with obesity of upper body subcutaneous adipose tissue in response to a mixed meal challenge by site specific cannulation of the superior epigastric vein. We will c…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Mindfulness or diet? study aims to soothe IBS without drugs
Symptom relief TerminatedThe study aims to compare the effect of mindfulness-based awareness training in Irritable Bowel Syndrome (IBS) (MB-IBS-EAT) with the dietary standard of care (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet) on patient's IBS symptoms
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Bladder cancer drug trial pulled before it even started
Disease control TerminatedThis is a Phase 3, open-label, randomized trial designed to evaluate the DFS of TURBT followed by NDV-1 (sustained-release gemcitabine-docetaxel) versus TURBT followed by surveillance for the treatment of participants with IR-NMIBC.
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Tiny bubbles of hydrogen and oxygen to be infused into humans for first time
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn whether hydrogen-oxygen ultrafine bubbles can be safely given through a vein (intravenous infusion) to adults. This is a first-in-human study, meaning this type of infusion has not been tested in people before. The study focuses on safe…
Phase: PHASE1 • Sponsor: Yayasan Inovasi Molekuler Indonesia (Indonesia Molecular Innovation Foundation) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Brain levels of supplement ingredient measured in healthy volunteers
Knowledge-focused Not yet recruitingThe purpose of this study is to determine the impact of Mitopure® consumption on urolithin A (UA) kinetics in cerebral spinal fluid (CSF).
Phase: NA • Sponsor: Amazentis SA • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Tiny study checks if extra MRIs during sarcoma radiation are doable
Knowledge-focused Not yet recruitingThis is a single arm study in which patients will undergo MRI studies at 3 non-SOC timepoints (end of weeks 1, 3, and 5) while receiving SOC RT for their soft tissue sarcoma.
Phase: NA • Sponsor: Andrew Frankart • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Scientists investigate best way to measure heart health signals
Knowledge-focused Not yet recruitingThis observational study aims to compare heart rate variability (HRV) parameters obtained from different analysis durations in healthy adults and to examine how these parameters relate to resting blood pressure values. HRV is a noninvasive measure commonly used to assess autonomi…
Phase: NA • Sponsor: Sinop University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Can a 10-Minute balance workout boost your stability and lungs?
Knowledge-focused Not yet recruitingThe study aims to examine the acute effects of balance exercises on balance performance in healthy individuals. It will be conducted with healthy males and females aged 18-25. The research is an experimental study with a single-blind pre-test/post-test design. Initially, partici…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Scientists track kidney Drug's journey through the body
Knowledge-focused Not yet recruitingThe study aims to evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]HRS-1780 following an oral single dose in healthy adult male participants.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Robot surgery from a distance: prostate cancer trial pulled before start
Disease control TerminatedThe goal of this clinical trial is to confirm the safety and feasibility of robotic telesurgery when used for the surgical management of prostate cancer in participates undergoing treatment for prostate cancer. In this clinical trial, participants will receive robotic telesurgery…
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Anesthesiologists surveyed on diversity education
Knowledge-focused Not yet recruitingTo date, there has not been an assessment of ASA members to determine satisfaction with DEI and cultural humility/structural competency education within institutions and programs. We developed a 24-question survey that will be distributed via email to current members of the Ameri…
Sponsor: Hospital for Special Surgery, New York • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Dental AI learns from 150 patients in new data study
Knowledge-focused Not yet recruitingThe purpose of this study is to prospectively collect fit-for-purpose, representative intraoral optical data using the LuminX Probe system to support development and validation of AI-enabled LuminX Probe software functions (AI-DSF). The collected data will be used for model train…
Phase: NA • Sponsor: LuminX • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Healthy men needed to test how food and ethnicity change drug levels
Knowledge-focused Not yet recruitingThis study aims to evaluate the effects of food or ethnicity on the pharmacokinetics and safety/tolerability of JPI-547 after a single oral administration in healthy male Korean, Caucasian, and Chinese participants.
Phase: PHASE1 • Sponsor: Onconic Therapeutics Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug KHN707 enters first human safety trial in china
Knowledge-focused Not yet recruitingThis is a single-center, randomized, double-blind, placebo-controlled study . The objective is to evaluate the safety , tolerability and PK profile of KHN707 tablets in Chinese healthy participants.
Phase: PHASE1 • Sponsor: Chengdu Kanghong Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New imaging agent aims to light up Hard-to-Find cancers
Diagnosis TerminatedThis is a single arm, pilot trial that evaluates the ability of a novel imaging agent (111In-ABD147) to detect metastatic cancer in participants with solid tumors. 111In-ABD147 is a high affinity Delta-like ligand 3 (DLL3) antigen binding domain fused to an engineered humanized F…
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New drug ABBV-722 put through interaction tests in healthy volunteers
Knowledge-focused OngoingThe objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC